Free Trial

Sage Therapeutics (SAGE) SEC Filings & 10K Form

Sage Therapeutics logo
$5.32 +0.05 (+0.95%)
(As of 09:32 AM ET)

Recent Sage Therapeutics SEC Filings

DateFilerForm TypeView
12/13/2024
7:47 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:42 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
5:40 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:14 PM
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:56 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
11/04/2024
2:28 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
1:10 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/01/2024
3:23 PM
Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/01/2024
3:24 PM
Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:10 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
3:20 PM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
10:37 AM
Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/17/2024
6:11 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
5:37 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
6:07 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
5:33 AM
Sage Therapeutics (Filer)
Form S-3ASR
07/31/2024
3:10 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
3:15 PM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
5:39 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
3:57 PM
Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:57 PM
Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:57 PM
COLA MICHAEL F (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:58 PM
FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:58 PM
Germano Geno J (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:58 PM
Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:58 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
11:15 AM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
06/10/2024
8:48 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
06/06/2024
8:54 AM
Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
04/25/2024
6:15 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
5:46 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:07 PM
Sage Therapeutics (Filer)
Form DEF 14A
04/24/2024
3:10 PM
Sage Therapeutics (Filer)
Form DEFA14A
04/24/2024
3:13 PM
Sage Therapeutics (Filer)
Form ARS
04/19/2024
7:31 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
5:35 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
7:34 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:49 AM
Sage Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
How this >10-cent coin is going to outperform Bitcoin (Ad)

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…

02/14/2024
6:20 AM
Sage Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
6:09 AM
RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
Form SC 13G
02/14/2024
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
4:13 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/13/2024
5:28 AM
Sage Therapeutics (Subject)
Form SC 13G/A
02/13/2024
5:28 AM
BB BIOTECH AG (Filed by)
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:49 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
02/08/2024
9:17 AM
Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/31/2024
4:25 PM
Sage Therapeutics (Subject)
Form SC TO-I/A
01/31/2024
3:50 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
9:04 AM
Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/23/2024
7:13 AM
Sage Therapeutics (Subject)
Form SC TO-I
01/08/2024
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:07 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
7:30 AM
Sage Therapeutics (Filer)
Form DEF 14A
12/19/2023
7:32 AM
Sage Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SAGE) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners